![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/36 | |
A61K 38/37 | |||
A61P 7/00 | |||
A61P 7/02 | |||
A61P 7/04 | |||
A61P 43/00 |
(11) | Number of the document | 3412305 |
(13) | Kind of document | T |
(96) | European patent application number | 18173179.5 |
Date of filing the European patent application | 2012-06-11 | |
(97) | Date of publication of the European application | 2018-12-12 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201161495884 P | 2011-06-10 | US | |
201161511901 P | 2011-07-26 | US | |
201161523790 P | 2011-08-15 | US |
(72) |
SCHEIFLINGER, Friedrich, AT
TURECEK, Peter, Dr., AT
EWENSTEIN, Bruce, US
WONG, Wing Yen, US
SUITER, Tobias M., DE
|
(73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka,
JP
|
(54) | TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |
TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |